173 related articles for article (PubMed ID: 19952723)
1. Neostigmine: how much is necessary for patients who receive a nondepolarizing neuromuscular blocking agent?
Lien CA
Anesthesiology; 2010 Jan; 112(1):16-8. PubMed ID: 19952723
[No Abstract] [Full Text] [Related]
2. Neostigmine injected 5 minutes after low-dose rocuronium accelerates the recovery of neuromuscular function.
Lederer W; Reiner T; Khuenl-Brady KS
J Clin Anesth; 2010 Sep; 22(6):420-4. PubMed ID: 20868962
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
[TBL] [Abstract][Full Text] [Related]
4. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
Kirkegaard-Nielsen H; Toft P; Severinsen IK; May O
Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
[TBL] [Abstract][Full Text] [Related]
5. Clinical limitations of acetylcholinesterase antagonists.
Caldwell JE
J Crit Care; 2009 Mar; 24(1):21-8. PubMed ID: 19272535
[TBL] [Abstract][Full Text] [Related]
6. Delayed reversal of a potentiated rocuronium neuromuscular block.
Dubois PE
Eur J Anaesthesiol; 2009 Apr; 26(4):350-2. PubMed ID: 19401670
[No Abstract] [Full Text] [Related]
7. Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Nicholson WT; Sprung J; Jankowski CJ
Pharmacotherapy; 2007 Aug; 27(8):1181-8. PubMed ID: 17655516
[TBL] [Abstract][Full Text] [Related]
8. [Investigations into neostigmine-induced inhibition of neuromuscular transmission].
Kitajima O; Suzuki T; Fukano N; Miyake E; Saeki S; Ogawa S
Masui; 2009 Apr; 58(4):410-5. PubMed ID: 19363999
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacology of sugammadex.
Bom A; Hope F; Rutherford S; Thomson K
J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous recovery or evoked reversal of neuromuscular block.
Mirakhur RK
Acta Anaesthesiol Scand Suppl; 1995; 106():62-5. PubMed ID: 8533549
[TBL] [Abstract][Full Text] [Related]
11. Comparison of recovery following rapacuronium, with and without neostigmine, and succinylcholine.
Hayes A; Breslin D; Reid J; Mirakhur RK
Anaesthesia; 2000 Sep; 55(9):859-63. PubMed ID: 10947748
[TBL] [Abstract][Full Text] [Related]
12. Reversal of mivacurium-induced neuromuscular block by neostigmine.
Baraka A
Middle East J Anaesthesiol; 2001 Feb; 16(1):3-5. PubMed ID: 11281046
[No Abstract] [Full Text] [Related]
13. Neuromuscular and cardiovascular effects of neostigmine and methyl-atropine administered at different degrees of rocuronium-induced neuromuscular block.
Van den Broek L; Proost JH; Wierda JM; Njoo MD; Hennis PJ
Eur J Anaesthesiol; 1994 Nov; 11(6):481-7. PubMed ID: 7851356
[TBL] [Abstract][Full Text] [Related]
14. Neostigmine/glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure.
Herbstreit F; Zigrahn D; Ochterbeck C; Peters J; Eikermann M
Anesthesiology; 2010 Dec; 113(6):1280-8. PubMed ID: 20980910
[TBL] [Abstract][Full Text] [Related]
15. The effect of reversal of myoneural blockade on cerebrospinal fluid pressure following cerebral aneurysm surgery.
Fawcett WJ; Chung RA; Fairley CJ; Hollway TE
Eur J Anaesthesiol; 1995 Nov; 12(6):591-5. PubMed ID: 8665882
[TBL] [Abstract][Full Text] [Related]
16. [The inhibition of synaptic acetylcholinesterase by postsynaptic muscle relaxants].
Danilov AF; Malygin VV
Eksp Klin Farmakol; 1997; 60(1):25-7. PubMed ID: 9162276
[TBL] [Abstract][Full Text] [Related]
17. [Erroneous attitudes in the use of neuromuscular blocking agents].
Ortiz-Gómez JR
Rev Esp Anestesiol Reanim; 2002 Feb; 49(2):65-8. PubMed ID: 12025249
[No Abstract] [Full Text] [Related]
18. Clinical implications of new neuromuscular concepts and agents: so long, neostigmine! So long, sux!
Lee C; Katz RL
J Crit Care; 2009 Mar; 24(1):43-9. PubMed ID: 19272538
[TBL] [Abstract][Full Text] [Related]
19. [Muscle relaxants in ambulatory anesthesia].
Takeda J
Masui; 2008 Jul; 57(7):845-52. PubMed ID: 18649639
[TBL] [Abstract][Full Text] [Related]
20. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
